VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GPAT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GPATGP-Act III Acquisition Corp.
$11.07$398M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

GPAT logoGP-Act III Acquisition Corp.(GPAT)Earnings, Financials & Key Ratios

GPAT•NASDAQ
$11.07
27.0× P/E·Price updated Jul 7, 2026
SectorFinancial ServicesIndustrySPACs & Shell CompaniesSub-IndustryGeneralist SPACs and blank checks
AboutGP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.Show more
  • EBITDA-$552K-106.4%
  • Net Income$12M+37.1%
  • EPS (Diluted)0.41-12.8%
  • ROE4.12%-32.9%

GPAT Price & Volume

GP-Act III Acquisition Corp. (GPAT) stock price & volume — 10-year historical chart

Loading chart...

SPAC Liquidity Constraints Threaten Future Deal Execution

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidation and deal-sourcing failure

Key Thesis Takeaways

  • GP-Act III Acquisition Corp.
  • remains a speculative shell vehicle currently devoid of operational revenue, with its financial health entirely dependent on sponsor-provided capital.
  • The entity faces significant risks as it approaches its business combination deadline, evidenced by a deteriorating cash position and mounting administrative overhead.
  • Investors should monitor the company's ability to secure a viable target before the current $119,400 cash reserve is fully exhausted by ongoing operational burn.

Verdict Logic

the company's current ratio of 0.17 and limited cash reserves of $119,400 suggest a high risk of liquidation if a business combination is not finalized immediately.

GPAT Growth Metrics

GP-Act III Acquisition Corp. (GPAT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-4.3%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-11.14%

Return on Capital

10 Years-6.15%
5 Years-6.15%
3 Years-0.96%
Last Year-0.18%

Peers Comparison

Key metrics vs top competitors for GP-Act III Acquisition Corp. (GPAT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
GPAT logoGPATGP-Act III Acquisition Corp.Current
$11.07$397.83M27.00——4.12%—
PSFE logoPSFEPaysafe Limited
$8.08$417.54M-2.57-0.2%-11.44%-28.61%—
ACIC logoACICAmerican Coastal Insurance Corporation
$11.52$558.31M5.3613.07%31.34%33.02%—
GS logoGSThe Goldman Sachs Group, Inc.
$1042.98$321.24B20.32-1.38%16.31%14.31%—
MS logoMSMorgan Stanley
$222.04$350.22B21.7711.48%15.13%16.22%—
JPM logoJPMJPMorgan Chase & Co.
$339.22$908.94B16.923.31%20.66%16.32%—

Compare GPAT vs Peers

GP-Act III Acquisition Corp. (GPAT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PSFE

Most directly comparable listed peer for GPAT.

Scale Benchmark

vs JPM

Larger-name benchmark to compare GPAT against a more recognizable public peer.

Peer Set

Compare Top 5

vs PSFE, ACIC, GS, MS

GPAT SEC Filings & Documents

GP-Act III Acquisition Corp. (GPAT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 14, 2026·SEC

Material company update

May 13, 2026·SEC

Material company update

May 7, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 26, 2026·SEC

FY 2025

Mar 28, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 14, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

Get notified when GPAT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

GPAT Frequently Asked Questions

GP-Act III Acquisition Corp. (GPAT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
Is GPAT profitable?

Yes, GP-Act III Acquisition Corp. (GPAT) is profitable, generating $11.1M in net income for fiscal year 2025.

Dividend & Returns
What is GPAT's return on equity?

GP-Act III Acquisition Corp. (GPAT) has a return on equity (ROE) of 4.1%. This is below average, suggesting room for improvement.

What is GP-Act III Acquisition Corp.'s free cash flow?

GP-Act III Acquisition Corp. (GPAT) had negative free cash flow of $0.3M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in GPAT back in 2020?

Total return calculator · dividends reinvested · 6+ years of data

See returns →